Amhwa Biopharm, a technological innovation-based company founded in 2010 with specialization in development and production of bioactives, APIs, medical cosmetology terminals and functional skin care cosmetics, has been providing quality products and services in the fields of medicine, skin care, food and agriculture worldwide for more than ten years.
It has developed into a leading global supplier of hyaluronic acid relying on its technological innovation and superior product quality. It was also awarded the honorary titles of high-tech enterprise, enterprises with specialization, refinement, specialization and novelty, gazelle enterprise and technology-based enterprise.
Amhwa Biopharm has now passed EU ECOCERT and COSMOS certification for organic cosmetics, and Certification of Suitability to Monograph of European Pharmacopoeia (CEP); obtained the certification documents WC GMP for API export to EU, Drug Manufacturing Certificate; registered with U.S. DMF and FDA; and passed certification of ISO 9001 - Quality Management System, ISO 22000 - Food Safety Management System, FSSC 22000 - Food Safety System, BRCS Global Standard for Food Safety, Kosher Food, HALAL, HACCP System, and NSF.
Amhwa Biopharm will, upholding the corporate vision of “building a leading global innovative biopharmaceutical company”, continue to help enterprises, society and customers to share a healthier and better life in the future! Inspire the life and make life better!
more >
Year of Establishment:
2010
Total Assets(USD):
less than 500,000
Total Number of Staff:
100-500
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
1. Pharm grade: injection and eye-dropping grade HA,
2. certifications: CEP, DMF, COSMOS, ECOCERT, FDA, KOSHER, HALALA
3. The biggest sodium hyaluronate factory
Patents and Copyrights:
Oligo-HA patents
Business Type:
Manufacturer
R&D capacity:
OEM,ODM,Own Brand
Annual Turnover(USD):
less than 500,000
Main Sales Markets:
Western Europe,Eastern Europe,Australasia
Other Competitive Advantages:
1. Pharm grade: injection and eye-dropping grade HA,
2. certifications: CEP, DMF, COSMOS, ECOCERT, FDA, KOSHER, HALALA
3. The biggest sodium hyaluronate factory
Patents and Copyrights:
Oligo-HA patents